2023
DOI: 10.1080/03639045.2023.2182122
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced skin penetration of Finasteride loaded DMSO-liposomes for the treatment of androgenic alopecia: comparison with conventional liposomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Similar findings were shown when comparing the ethosomal formulation (F6) with 400 mg PL (70.30 ± 1.81%) and formulation (F11) with 200 mg PL (44.43 ± 1.33%). The increase in the EE% with an increase in the PL concentration could be related to the lipophilicity of RS, since the lipophilic medication would find a high lipid surface area to be encapsulated in the lipoid phase of the vesicles [41].…”
Section: Effect Of Independent Factors On Ee% (R 3 )mentioning
confidence: 99%
“…Similar findings were shown when comparing the ethosomal formulation (F6) with 400 mg PL (70.30 ± 1.81%) and formulation (F11) with 200 mg PL (44.43 ± 1.33%). The increase in the EE% with an increase in the PL concentration could be related to the lipophilicity of RS, since the lipophilic medication would find a high lipid surface area to be encapsulated in the lipoid phase of the vesicles [41].…”
Section: Effect Of Independent Factors On Ee% (R 3 )mentioning
confidence: 99%
“…The expression of sulfotransferase in the scalp is different in different individuals, explaining the heterogeneity in clinical responses to MXD therapy [11]. In some studies, the skin permeability and retention of FIN and MXD were enhanced using liposome-based delivery systems [12][13][14]. For example, the use of FIN has been limited because its systemic administration can cause sexual dysfunction.…”
Section: Introductionmentioning
confidence: 99%
“…To solve this problem, DMSO-modified liposomes were prepared for the topical delivery of FIN. The permeation capacity of DMSO could promote FIN delivery to HFs, mitigating the adverse effects of systemic administration [13]. In addition to drug treatment, HF transplantation is another therapeutic option for hair loss.…”
Section: Introductionmentioning
confidence: 99%